Jens Volkmann

Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position.

Deep brain stimulation for dystonia: patient selection and evaluation.

Introduction to the programming of deep brain stimulators.

The cerebral oscillatory network of parkinsonian resting tremor.

Deep brain stimulation of the subthalamic nucleus enhances emotional processing in Parkinson disease.

Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.

Effect of subthalamic deep brain stimulation on the function of the urinary bladder.

Deep brain stimulation for the treatment of Parkinson's disease.

Long-term results of bilateral pallidal stimulation in Parkinson's disease.

Most effective stimulation site in subthalamic deep brain stimulation for Parkinson's disease.

Pallidal stimulation for dystonia.

Praying-induced oromandibular dystonia.

Depression and Parkinson's disease.

Dementia in idiopathic Parkinson's syndrome.

Deep brain stimulation in late stage Parkinson's disease: a retrospective cost analysis in Germany.

Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease?

[Non-medical neurosurgical Parkinson treatment].

Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease.

Patients with Parkinson's disease learn to control complex systems-an indication for intact implicit cognitive skill learning.

Basic algorithms for the programming of deep brain stimulation in Parkinson's disease.

Deep brain stimulation: postoperative issues.

The impact of normal aging and Parkinson's disease on response preparation in task-switching behavior.

A randomized trial of deep-brain stimulation for Parkinson's disease.

Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease.

Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease.

Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration.

Pallidal deep-brain stimulation in primary generalized or segmental dystonia.

Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease.

Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor.

Update on surgery for Parkinson's disease.

Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial.

Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation.

Managing Parkinson's disease with continuous dopaminergic stimulation.

Deep brain stimulation in Parkinson's disease following fetal nigral transplantation.

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.

High-frequency stimulation of the subthalamic nucleus increases pallidal neuronal firing rate in a patient with Parkinson's disease.

Subthalamic nucleus stimulation restores corticospinal facilitation in Parkinson's disease.

Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy.

Acquired stuttering after pallidal deep brain stimulation for dystonia.

Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.

Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.

Internal carotid artery dissection and stroke after SCUBA diving: a case report and review of the literature.

Proprioception and motor control in Parkinson's disease.

ATP13A2 variants in early-onset Parkinson's disease patients and controls.

Inducing homeostatic-like plasticity in human motor cortex through converging corticocortical inputs.

Cortical correlates of the basic and first harmonic frequency of Parkinsonian tremor.

Secondary failure after ten years of pallidal neurostimulation in a patient with advanced Parkinson's disease.

Camptocormia in idiopathic Parkinson's disease: a focal myopathy of the paravertebral muscles.

Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.

Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.

Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease.

Gait ataxia in essential tremor is differentially modulated by thalamic stimulation.

Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues.

Subthalamic deep brain stimulation increases pallidal firing rate and regularity.

Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation.

Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration.

Modulation of gait coordination by subthalamic stimulation improves freezing of gait.

Axonal failure during high frequency stimulation of rat subthalamic nucleus.

Successful deep brain stimulation in a case of posttraumatic tremor and hemiparkinsonism.

No evidence for THAP1/DYT6 variants as disease modifiers in DYT1 dystonia.

Long-Term management of DBS in dystonia: response to stimulation, adverse events, battery changes, and special considerations.

Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.

Identification and functional analysis of novel THAP1 mutations.

Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study.

Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson's disease.

The Wilson films--Parkinson's disease.

Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?

Deep brain stimulation in Parkinson's disease: opening up the race towards better technology.

A role for locus coeruleus in Parkinson tremor.

The atypical subthalamic nucleus--an anatomical variant relevant for stereotactic targeting.

Stimulation site within the MRI-defined STN predicts postoperative motor outcome.

Lower limb joints kinematics in essential tremor and the effect of thalamic stimulation.

Differential effect of dopa and subthalamic stimulation on vestibular activity in Parkinson's disease.

Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.

The influence of dopaminergic striatal innervation on upper limb locomotor synergies.

Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review.

Botulinum neurotoxin treatment improves force regulation in writer's cramp.

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.

Dystonia rating scales: critique and recommendations.

The central oscillatory network of orthostatic tremor.

Postoperative management of deep brain stimulation in Parkinson's disease.

The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus.

Deep brain stimulation for gait and postural symptoms in Parkinson's disease.

Commentary.

Motor outcome of dystonic camptocormia treated with pallidal neurostimulation.

Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor.

Subthalamic deep brain stimulation restores automatic response activation and increases susceptibility to impulsive behavior in patients with Parkinson's disease.

Gait initiation in children with Rett syndrome.

Cutaneous neuropathy in Parkinson's disease: a window into brain pathology.

Coordinated reset neuromodulation for Parkinson's disease: proof-of-concept study.

Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.

Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.

EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.

Selective changes of ocular vestibular myogenic potentials in Parkinson's disease.

Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia.

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

The medical treatment of patients with Parkinson's disease receiving subthalamic neurostimulation.

Short pulse width widens the therapeutic window of subthalamic neurostimulation.

Subthalamic nucleus stimulation improves Parkinsonian gait via brainstem locomotor centers.

Cognitive outcome of pallidal deep brain stimulation for primary cervical dystonia: One year follow up results of a prospective multicenter trial.

Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy.

Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.

Deep Brain Stimulation in Neurological and Psychiatric Disorders.

Skin biopsies in the differential diagnosis of parkinsonism: are we ready for simplified protocols?

Reply to comment on: Short pulse width widens the therapeutic window of subthalamic neurostimulation.

Non-Motor Symptoms of Essential Tremor Are Independent of Tremor Severity and Have an Impact on Quality of Life.

Directional deep brain stimulation of the subthalamic nucleus: A pilot study using a novel neurostimulation device.

375 DIRECT DBS: A Prospective, Multicenter Clinical Trial With Blinding for a Directional Deep Brain Stimulation Lead.

Innovations in deep brain stimulation methodology.

Split-belt locomotion in Parkinson's disease links asymmetry, dyscoordination and sequence effect.

Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review.

Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?

Distinctive neuronal firing patterns in subterritories of the subthalamic nucleus.

Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.

Unmet Needs in the Management of Cervical Dystonia.

ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia.

Targeting of the Subthalamic Nucleus for Deep Brain Stimulation: A Survey Among Parkinson Disease Specialists.

Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies.

Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.

Corrigendum: Unmet Needs in the Management of Cervical Dystonia.

Development and validation of the deep brain stimulation impairment scale (DBS-IS).

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.

Intraoperative Thresholds for Capsular Stimulation Are Reliable for Chronic Pallidal Deep Brain Stimulation in Dystonia.

Effects of DBS in parkinsonian patients depend on the structural integrity of frontal cortex.

Perception of Time in Music in Patients with Parkinson's Disease-The Processing of Musical Syntax Compensates for Rhythmic Deficits.

Parkinson disease.

Reply: Clinical approach to delayed-onset cerebellar impairment following deep brain stimulation for tremor.

Adult-Onset Niemann-Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult.

Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α-synuclein Parkinson's disease rat model.

The deep brain stimulation impairment scale (DBS-IS).

Connectivity predicts deep brain stimulation outcome in Parkinson's disease.

Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registry.

Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease.

Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia.

Reply to "Can STN DBS protect both nigral somata and innervation of the striatum?"

Subthalamotomy for Parkinson's disease: back to the future?

Postoperative rehabilitation after deep brain stimulation surgery for movement disorders.

STN DBS for Advanced Parkinson Disease Simultaneously Alleviates Cluster Headache.

Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects.

Retinal changes in Parkinson's disease and glaucoma.

Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?

Deep brain stimulation: current challenges and future directions.

Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registry.

Stenosis Length and Degree Interact With the Risk of Cerebrovascular Events Related to Internal Carotid Artery Stenosis.

Electrical Stimulation of the Mesencephalic Locomotor Region Attenuates Neuronal Loss and Cytokine Expression in the Perifocal Region of Photothrombotic Stroke in Rats.

Electrical Stimulation of the Mesencephalic Locomotor Region Has No Impact on Blood-Brain Barrier Alterations after Cerebral Photothrombosis in Rats.

Striatal dopaminergic dysregulation and dystonia-like movements induced by sensorimotor stress in a pharmacological mouse model of rapid-onset dystonia-parkinsonism.

[Care of patients with Parkinson's disease in Germany].

A Single Session of Anodal Cerebellar Transcranial Direct Current Stimulation Does Not Induce Facilitation of Locomotor Consolidation in Patients With Multiple Sclerosis.

Technology of deep brain stimulation: current status and future directions.

Gait initiation in progressive supranuclear palsy: brain metabolic correlates.

Mesencephalic Electrical Stimulation Reduces Neuroinflammation after Photothrombotic Stroke in Rats by Targeting the Cholinergic Anti-Inflammatory Pathway.

The evolution of dystonia-like movements in TOR1A rats after transient nerve injury is accompanied by dopaminergic dysregulation and abnormal oscillatory activity of a central motor network.